Profile | GDS4284 / 202731_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 3133.77 | 89 |
GSM687648 | Patient 402 control | 2761.8 | 88 |
GSM687653 | Patient 403 control | 3879.4 | 91 |
GSM687658 | Patient 404 control | 3383.56 | 90 |
GSM687663 | Patient 411 control | 3690.48 | 91 |
GSM687668 | Patient 422 control | 3268.58 | 90 |
GSM687673 | Patient 424 control | 5299.36 | 94 |
GSM687678 | Patient 425 control | 5303.16 | 94 |
GSM687683 | Patient 427 control | 2895.33 | 88 |
GSM687688 | Patient 428 control | 2895.36 | 88 |
GSM687695 | Patient 441 control | 3586.68 | 91 |
GSM687699 | Patient 443 control | 3826.96 | 91 |
GSM687704 | Patient 444 control | 3018.01 | 89 |
GSM687707 | Patient 448 control | 4576.03 | 93 |
GSM687712 | Patient 449 control | 4463.88 | 92 |
GSM687719 | Patient 450 control | 3631.66 | 91 |
GSM687724 | Patient 451 control | 3378.81 | 90 |
GSM687728 | Patient 452 control | 4383.64 | 92 |
GSM687646 | Patient 401 treated 24h | 4698.08 | 93 |
GSM687649 | Patient 402 treated 24h | 2657.23 | 87 |
GSM687665 | Patient 411 treated 24h | 3887.52 | 91 |
GSM687651 | Patient 402 treated 4 weeks | 3198.86 | 89 |
GSM687667 | Patient 411 treated 4 weeks | 4200.37 | 92 |
GSM687670 | Patient 422 treated 24h | 3404.61 | 90 |
GSM687671 | Patient 422 treated 4 weeks | 3874.73 | 91 |
GSM687654 | Patient 403 treated 24h | 4060.91 | 91 |
GSM687675 | Patient 424 treated 24h | 6372.04 | 95 |
GSM687685 | Patient 427 treated 24h | 2299.85 | 86 |
GSM687656 | Patient 403 treated 4 weeks | 5150.08 | 93 |
GSM687677 | Patient 424 treated 4 weeks | 4518.69 | 93 |
GSM687687 | Patient 427 treated 4 weeks | 3813.14 | 91 |
GSM687692 | Patient 428 treated 4h | 3683.84 | 91 |
GSM687716 | Patient 449 treated 4h | 4023.16 | 91 |
GSM687722 | Patient 450 treated 4h | 3426.22 | 90 |
GSM687680 | Patient 425 treated 24h | 4876.01 | 93 |
GSM687690 | Patient 428 treated 24h | 3092.39 | 89 |
GSM687700 | Patient 443 treated 24h | 3255.06 | 90 |
GSM687705 | Patient 444 treated 24h | 2593.03 | 87 |
GSM687714 | Patient 449 treated 24h | 4609.18 | 93 |
GSM687721 | Patient 450 treated 24h | 3739.62 | 91 |
GSM687682 | Patient 425 treated 4 weeks | 3033.49 | 89 |
GSM687694 | Patient 428 treated 4 weeks | 4604.21 | 93 |
GSM687702 | Patient 443 treated 4 weeks | 3627.76 | 91 |
GSM687718 | Patient 449 treated 4 weeks | 3567.01 | 91 |
GSM687723 | Patient 450 treated 4 weeks | 3920.7 | 91 |
GSM687661 | Patient 404 treated 4h | 4249.93 | 92 |
GSM687710 | Patient 448 treated 4h | 5215.71 | 93 |
GSM687726 | Patient 451 treated 4h | 5387.63 | 94 |
GSM687730 | Patient 452 treated 4h | 1440.14 | 80 |
GSM687660 | Patient 404 treated 24h | 2029.8 | 86 |
GSM687697 | Patient 441 treated 24h | 3457.47 | 91 |
GSM687709 | Patient 448 treated 24h | 5475.34 | 94 |
GSM687725 | Patient 451 treated 24h | 4914.82 | 93 |
GSM687729 | Patient 452 treated 24h | 3285.84 | 90 |
GSM687727 | Patient 451 treated 4 weeks | 2028.87 | 84 |
GSM687731 | Patient 452 treated 4 weeks | 5005.31 | 93 |